124 related articles for article (PubMed ID: 9723586)
1. Severe autoimmune hepatitis in a chronic myeloid leukemia patient treated with interferon alpha and with complete genetic response.
Steegmann JL; Requena MJ; García-Buey ML; Granados E; Romero R; Fernández-Rañada JM; Moreno R
Am J Hematol; 1998 Sep; 59(1):95-7. PubMed ID: 9723586
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha induced autoimmune hepatitis in a patient with Philadelphia chromosome-positive chronic myeloid leukemia with cytogenetically normal T lymphocytes.
Ariad S; Song E; Cohen R; Bezwoda WR
Mol Biother; 1992 Sep; 4(3):139-42. PubMed ID: 1445668
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune mediated thrombocytopenia associated with the use of interferon-alpha in chronic myeloid leukemia.
Zuffa E; Vianelli N; Martinelli G; Tazzari P; Cavo M; Tura S
Haematologica; 1996; 81(6):533-5. PubMed ID: 9009441
[TBL] [Abstract][Full Text] [Related]
4. High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-alpha.
Steegmann JL; Requena MJ; Martín-Regueira P; De La Cámara R; Casado F; Salvanés FR; Fernández Rañada JM
Am J Hematol; 2003 Mar; 72(3):170-6. PubMed ID: 12605388
[TBL] [Abstract][Full Text] [Related]
5. Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M-BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN-alpha).
Steegmann JL; Requena MJ; Casado LF; Pico M; Peñarrubia MJ; Ferro MT; Resino M; Fernandez-Rañada JM
Am J Hematol; 1996 Nov; 53(3):169-74. PubMed ID: 8895687
[TBL] [Abstract][Full Text] [Related]
6. Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia.
Sacchi S; Kantarjian H; O'Brien S; Cohen PR; Pierce S; Talpaz M
J Clin Oncol; 1995 Sep; 13(9):2401-7. PubMed ID: 7666100
[TBL] [Abstract][Full Text] [Related]
7. A cytogenetic and fluorescence in situ hybridization evaluation of interferon-alpha in the treatment of chronic myeloid leukemia.
Itoh T; Tamura S; Takemoto Y; Kakishita E
Int J Mol Med; 1999 Dec; 4(6):659-63. PubMed ID: 10567680
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing anti-interferon-alpha antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (alpha 2a) and lymphoblastoid interferon-alpha.
Russo D; Candoni A; Zuffa E; Minisini R; Silvestri F; Fanin R; Zaja F; Martinelli G; Tura S; Botta G; Baccarani M
Br J Haematol; 1996 Aug; 94(2):300-5. PubMed ID: 8759890
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of cytogenetic response in Ph+ chronic myeloid leukemia patients treated with interferon alpha].
Hong H; Qiu JY; Lai YY; Shi Y; He Q; Dang H; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):269-73. PubMed ID: 12844411
[TBL] [Abstract][Full Text] [Related]
10. [Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa].
Tóthová E; Stecová N; Kafková A; Fricová M; Svorcová E
Vnitr Lek; 2002 May; 48(5):380-3. PubMed ID: 12061203
[TBL] [Abstract][Full Text] [Related]
11. Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy.
Martinelli G; Testoni N; Amabile M; Bonifazi F; De Vivo A; Farabegoli P; Terragna C; Montefusco V; Ottaviani E; Saglio G; Russo D; Baccarani M; Rosti G; Tura S
Bone Marrow Transplant; 2000 Apr; 25(7):729-36. PubMed ID: 10745258
[TBL] [Abstract][Full Text] [Related]
12. Hypertriglyceridemia may be severe in CML patients treated with interferon-alpha.
Peñarrubia MJ; Steegmann JL; Lavilla E; Casado F; Requena MJ; Picó M; Arranz R; Fernández-Rañada JM
Am J Hematol; 1995 Jul; 49(3):240-1. PubMed ID: 7604817
[TBL] [Abstract][Full Text] [Related]
13. Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-alpha.
Hochhaus A; Lin F; Reiter A; Skladny H; van Rhee F; Shepherd PC; Allan NC; Hehlmann R; Goldman JM; Cross NC
Br J Haematol; 1995 Sep; 91(1):126-31. PubMed ID: 7577619
[TBL] [Abstract][Full Text] [Related]
14. Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B.
Cianciara J; Laskus T
Dig Dis Sci; 1995 Aug; 40(8):1842-4. PubMed ID: 7648989
[TBL] [Abstract][Full Text] [Related]
15. Result of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older.
Cortes J; Kantarjian H; O'Brien S; Robertson LE; Pierce S; Talpaz M
Am J Med; 1996 Apr; 100(4):452-5. PubMed ID: 8610733
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous sarcoidosis in a patient with Philadelphia-positive chronic myelogenous leukemia treated with interferon-alpha.
Yavorkovsky LL; Carrum G; Bruce S; McCarthy PL
Am J Hematol; 1998 May; 58(1):80-1. PubMed ID: 9590155
[TBL] [Abstract][Full Text] [Related]
17. [Treatment with interferon alfa-2a in the chronic phase of Philadelphia-positive chronic myeloid leukemia].
Steegmann JL; Lavilla E; Somolinos N; Pérez-Sánchez M; Lamana M; Olmeda F; Cámara R; Arranz R; Ferro MT; Fernández-Rañada JM
Sangre (Barc); 1992 Oct; 37(5):375-81. PubMed ID: 1293778
[TBL] [Abstract][Full Text] [Related]
18. A prospective comparison of alpha-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients. The Italian Cooperative Study Group on Chronic Myeloid Leukemia.
Haematologica; 1992; 77(3):204-14. PubMed ID: 1427426
[TBL] [Abstract][Full Text] [Related]
19. Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukaemia.
Melo JV; Hochhaus A; Yan XH; Goldman JM
Br J Haematol; 1996 Mar; 92(3):684-6. PubMed ID: 8616036
[TBL] [Abstract][Full Text] [Related]
20. BCR-ABL-positive progenitors in chronic myeloid leukaemia patients in complete cytogenetic remission after treatment with interferon-alpha.
Reiter A; Marley SB; Hochhaus A; Sohal J; Raanani P; Hehlmann R; Gordon MY; Goldman JM; Cross NC
Br J Haematol; 1998 Sep; 102(5):1271-8. PubMed ID: 9753056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
